Meeting
2015 ASCO Annual Meeting
Immunotoxin therapy in animal model of HuD antigen positive small cell lung cancer.
Authors
Bo Wang
Albert Einstein College of Medicine, New York, NY
Bo Wang , Wei Lu , Peter Dowling
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics and Translational Research
Sub Track
Immunotherapy and Biologic Therapy
Citation
J Clin Oncol 33, 2015 (suppl; abstr 3033)
DOI
10.1200/jco.2015.33.15_suppl.3033
Abstract #
3033
Poster Bd #
359
Abstract Disclosures
Similar Posters
Poster
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Immunotoxin and bcl-2 inhibitor combination therapy targeting chondroitin sulfate proteoglycan 4.
First Author: Xin Yu
Poster
2013 ASCO Annual Meeting
HM1.24/CD317-directed immunotoxin to eliminate malignant plasma cells in vitro and in vivo.
First Author: Martin Gramatzki
Poster
2023 ASCO Annual Meeting
A theranostic approach: Imaging and therapy of delta-like ligand 3–expressing small cell lung cancers.
First Author: Salomon Tendler
Poster
2023 ASCO Annual Meeting
A phase 1 study of AGEN2373, a novel CD137 agonist antibody designed to avoid hepatoxicity, in patients with advanced solid tumors.
First Author: Minal A. Barve